According to the text, drug regulators and cancer researchers in Brazil are
a) for the proposal of providing the compound to people with terminal cancer immediately.
|
b) demonstrating phosphoethanolamine is safe and effective and giving it to patients who go to court.
|
c) concerned and turning to the courts to access drugs that the state health-care system does not dispense.
|
d) disgruntled, once phosphoethanolamine is being given to patients outside of a clinical trial.
|
e) granting orders for the largest university in Brazil to provide phosphoethanolamine to cancer patients.
|
Copyright © Tecnolegis - 2010 - 2024 - Todos os direitos reservados.